Virax Biolabs Group Limited (VRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2023 | 09-2022 | 03-2022 | 03-2021 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -5,458 | -1,454 | -1,750 | -673 |
| Other Working Capital | -182 | -1,092 | 644 | 60 |
| Other Operating Activity | 1,460 | 250 | 297 | 23 |
| Operating Cash Flow | $-4,180 | $-2,296 | $-809 | $-590 |
| Cash Flows From Investing Activities | ||||
| Other Investing Activity | -178 | 0 | 0 | 0 |
| Investing Cash Flow | $-178 | $N/A | $0 | $0 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 13,689 | 6,845 | 813 | 585 |
| Financing Cash Flow | $13,689 | $6,845 | $813 | $585 |
| Beginning Cash Position | 22 | 22 | 18 | 23 |
| End Cash Position | 9,353 | 4,570 | 22 | 18 |
| Net Cash Flow | $9,331 | $4,548 | $4 | $-5 |
| Free Cash Flow | ||||
| Operating Cash Flow | -4,180 | -2,296 | -809 | -590 |
| Free Cash Flow | -4,180 | -2,296 | -809 | -590 |